Upper Respiratory Tract Infection (Common Cold) Prevention & Support Protocol
Primary Stack
Core supplements with strongest evidenceSupports immune cell function; regular supplementation reduces cold duration and severity, especially in physically stressed individuals
Inhibits viral replication; zinc lozenges taken within 24 hours of symptom onset can reduce cold duration
Supporting Stack
Additional supplements for enhanced resultsImmunomodulators that enhance innate immune response; may reduce URTI incidence and duration
Supporting Studies (1)
Supports innate immunity via cathelicidin production; deficiency increases respiratory infection risk
Immunostimulant that may reduce cold incidence and duration; most effective when taken early
Antiviral properties against influenza and some cold viruses; may reduce duration and severity
Traditional herb with immunostimulatory effects; may reduce severity and duration of URTI symptoms
Stimulates immune response and may have direct antiviral effects; studied for acute bronchitis and URTIs
Support gut-immune axis; may reduce respiratory infection incidence and duration
How This Protocol Works
Simple Explanation
Upper respiratory tract infections (URTIs)—including the common cold, pharyngitis, and sinusitis—are among the most frequent illnesses people experience. Most are viral and self-limiting, but they cause significant discomfort and missed work/school. Adults average 2-4 colds per year; children even more. While there's no cure for the common cold, certain supplements can help prevent infections and reduce their duration and severity.
IMPORTANT: Most URTIs are viral and don't require antibiotics. See a doctor if symptoms are severe, prolonged (>10 days), or you have high fever, severe headache, or difficulty breathing.
Expected timeline: Zinc lozenges: effects begin within hours/days of onset. Vitamin C: ongoing benefit with regular use. Beta-glucans/Vitamin D/Probiotics: 2-4 weeks for prevention effects to establish. Echinacea/Elderberry/Andrographis: best when started at first sign of illness.
Clinical Perspective
Upper respiratory tract infections encompass viral infections of the nasopharynx, pharynx, larynx, and trachea. Common pathogens: rhinoviruses (30-50%), coronaviruses (10-15%), RSV, influenza, parainfluenza, adenovirus, enteroviruses. Average duration 7-10 days. Complications include sinusitis, otitis media, lower respiratory tract infection, asthma exacerbation. Treatment is primarily supportive. Antibiotics are not indicated for uncomplicated viral URTIs.
CRITICAL: Bacterial complications require medical evaluation. Red flags: high fever >39°C, severe symptoms, symptoms >10 days without improvement, biphasic illness pattern (improvement then worsening). Influenza-like illness with risk factors may warrant antivirals.
Biomarker targets: Clinical endpoints (symptom severity scores, duration, incidence), 25(OH)D levels for vitamin D status, serum zinc if deficiency suspected.
Protocol notes: Hand hygiene is most effective prevention. Avoid touching face. Adequate sleep (7-9 hrs) reduces infection risk. Manage stress (increases susceptibility). Regular exercise (moderate) enhances immunity. Avoid overtraining (immunosuppressive). Humid air may ease symptoms. Saline nasal irrigation for symptom relief. Honey (≥1 year old children and adults) for cough. Adequate hydration. Rest. Avoid alcohol and smoking (impair immunity). Annual influenza vaccination. Symptomatic treatment: acetaminophen/NSAIDs for pain/fever, decongestants, antihistamines (limited benefit). Antivirals for influenza if indicated (within 48h). Zinc intranasal products should be avoided (risk of anosmia).